or
Remember me
Back
Travelers Reports Net Income per Diluted Share of $2.21 and Quarterly Record Operating Income per Diluted Share of $2.22 for the Third Quarter Download PDF Operating Return on Equity and Return on Equity of 15.5% and 13.6%, Respectively Operating and net income of $867 million and $864 million, respectively. Underlying underwriting margin improvement continued across all segments, and net investment income remained strong due to alternative investment performance. Written rate gains were strong across all segments. Book value per share of $67.81, up 11% from end of prior year quarter and 9% from year-end 2011. Board of Directors approved quarterly dividend per share of $0.46. NEW YORK--(BUSINESS WIRE)--Oct. 18, 2012-- The Travelers Companies, Inc. today reported net income of $864 million, or $2.21 per diluted share, for the quarter ended September 30, 2012, compared to $333 million, or $0.79 per diluted share, in the prior year quarter. Operating income in the current quarter was $867 million, or $2.22 per diluted share, compared to $332 million, or $0.79 per diluted share, in the prior year quarter. The increase in net and operating income in the current quarter compared to the prior year quarter was primarily driven by lower catastrophe losses and higher underlying underwriting results. Catastrophe losses in the current quarter were $59 million after tax ($91 million pre tax), compared to $394 million after tax ($606 million pre tax) in the prior year quarter. https://investor.travelers.com/phoenix.zhtml?c=177842&p=irol-newsArticle&ID=1746986&highlight= 10Q – Third Quarter 2012
--------------------------------------
TRV Chart https://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=&insttype=Stock&symb=trv&time=6&startdate=1%2F4%2F1999&enddate=1%2F8%2F2012&freq=1&compidx=aaaaa%3A0&comptemptext=&comp=&ma=4&maval=9+15+50&uf=7168&lf=1&lf2=4&lf3=2&type=4&style=320&size=3&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11&x=0&y=0 Analyst Estimates https://www.marketwatch.com/investing/stock/trv/analystestimates
